NCT07066722View on ClinicalTrials.gov

A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

November 6, 2025

Study Completion Date

November 6, 2025

Conditions
HIV Infections
Interventions
DRUG

VH4524184

VH4524184 will be administered.

DRUG

Itraconazole

Itraconazole will be administered.

DRUG

Rifabutin

Rifabutin will be administered.

DRUG

Phenytoin

Extended phenytoin sodium will be administered.

DRUG

Metformin

Metformin will be administered.

Trial Locations (2)

66219

RECRUITING

GSK Investigational Site, Lenexa

84124

RECRUITING

GSK Investigational Site, Salt Lake City

Sponsors

Lead Sponsor

ViiV Healthcare
All Listed Sponsors
lead

ViiV Healthcare

INDUSTRY

NCT07066722 - A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults | Biotech Hunter | Biotech Hunter